UPClytics
Alle Fälle anzeigen

UPC APP 14061/2024

·EP3769722: LOW PROFILE DELIVERY SYSTEM FOR TRANSCATHETER HEART VALVE

Verfahrensdetails
Status
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien
Kläger
Vertreter: Jens Olsson; Siddharth Kusumakar; Tessa Waldron
Beklagte
Vertreter: Andreas von Falck (Hogan Lovells International LLP); Alexander Klicznik (Hogan Lovells International LLP); Kerstin Jonen (Hogan Lovells International LLP)
Division
Nordic-Baltic RD
Richter
Technology
Pharmaceutical & Medical
Sprache
Erste Entscheidung
20. Aug. 2024
Entscheidungen
  • 2024-08-20
    Generic application

    Procedural order from the Nordic-Baltic Regional Division (UPC_CFI_380/2023) dismissing Meril entities' application for security for costs against Edwards Lifesciences in an infringement action concerning EP 3 769 722. The Court held that the mere fact that the claimant is located in the United States does not justify ordering security for costs, as this would constitute an unjustified restriction of the right to an effective remedy; the risk of unenforceability in the US was deemed insufficient.

    Rechtsfragen:Security for costs (Art. 69.4 UPCA, R. 158 RoP)Right to effective remedyEnforcement of UPC orders in non-EU states
Dokumente
  • 9FFD2D61914C79B51A999677EA259D6F_en.pdf2024-08-20EN